Text Message Intervention for Teens with Type 1 Diabetes Preserves HbA1c: Results of a Randomized Controlled Trial

被引:14
|
作者
McGill, Dayna E. [1 ]
Laffel, Lori M. [1 ]
Volkening, Lisa K. [1 ]
Butler, Deborah A. [1 ]
Levy, Wendy L. [2 ]
Wasserman, Rachel M. [2 ]
Anderson, Barbara J. [2 ]
机构
[1] Harvard Med Sch, Joslin Diabet Ctr, Sect Clin Behav & Outcomes Res, Pediat Adolescent & Young Adult Sect, One Joslin Pl, Boston, MA 02215 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
关键词
Type; 1; diabetes; Text messaging; HbA1c; Pediatrics; Adolescents; HEMOGLOBIN A(1C) LEVELS; GLYCEMIC CONTROL; TREATMENT ADHERENCE; YOUNG-ADULTS; ADOLESCENTS; FREQUENCY; CHILDREN; GLUCOSE; OUTCOMES; BOLUSES;
D O I
10.1089/dia.2019.0350
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Teens with type 1 diabetes (T1D) often struggle with diabetes self-management, which may lead to suboptimal self-care and worsening hemoglobin A1c (HbA1c). Innovative strategies are needed to improve self-care and protect against glycemic decline, especially during adolescence. We aimed to assess the impact on HbA1c of two interventions, problem-solving and text messaging, in teens with T1D. Methods: In a two-site randomized controlled trial, teens (N = 301) 13-17 years of age with T1D were randomized to one of the four groups using a 2 x 2 factorial design: Teenwork (TW), Text Messaging (Text), TW+Text, or Usual Care. TW intervention included problem-solving aimed at improving T1D self-care for blood glucose (BG) monitoring and insulin bolus dosing. Text intervention involved text reminders to check BG. The primary outcome was change in HbA1c from baseline to 12 months. Results: At baseline, teens (51% female, 78% white, 59% pump-treated) were (mean +/- SD) 15.0 +/- 1.3 years, had diabetes duration of 6.5 +/- 3.7 years, and HbA1c 8.5% +/- 1.1%. There was no significant difference in HbA1c over time by study group. Responsiveness to text reminders by teens in the TEXT and TW+TEXT predicted glycemic benefit; TW did not. Conclusions: Despite no HbA1c difference by study group, greater response to text message reminders to check BG led to better glycemic control and no deterioration in HbA1c; the problem-solving intervention did not. Given the high penetration of mobile phones and the wide acceptance of text messaging among teens in general, it is encouraging that a text messaging intervention can preserve HbA1c, thus preventing the expected deterioration in glycemic control often seen in teens with T1D.
引用
收藏
页码:374 / 382
页数:9
相关论文
共 50 条
  • [1] Text-Message Intervention for Teens with Type 1 Diabetes (T1D) Preserves A1c: Results of an RCT
    Laffel, Lori M.
    Volkening, Lisa K.
    Levy, Wendy L.
    Butler, Deborah A.
    Anderson, Barbara J.
    [J]. DIABETES, 2017, 66 : LB52 - LB52
  • [2] Effectiveness and acceptability of a text message intervention (DTEXT) on HbA1c and self-management for people with type 2 diabetes. A randomized controlled trial
    Waller, Karen
    Furber, Susan
    Bauman, Adrian
    Allman-Farinelli, Margaret
    van den Dolder, Paul
    Hayes, Alison
    Facci, Franca
    Franco, Lisa
    Webb, Alison
    Moses, Robert
    Cook, Rebecca
    Gugusheff, Jessica
    Owen, Katherine
    Colagiuri, Stephen
    [J]. PATIENT EDUCATION AND COUNSELING, 2021, 104 (07) : 1736 - 1744
  • [3] Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial
    Hermanides, J.
    Norgaard, K.
    Bruttomesso, D.
    Mathieu, C.
    Frid, A.
    Dayan, C. M.
    Diem, P.
    Fermon, C.
    Wentholt, I. M. E.
    Hoekstra, J. B. L.
    DeVries, J. H.
    [J]. DIABETIC MEDICINE, 2011, 28 (10) : 1158 - 1167
  • [4] Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial
    Ibrahim, Nour
    Treluyer, Jean-Marc
    Briand, Nelly
    Godot, Cecile
    Polak, Michel
    Beltrand, Jacques
    [J]. PLOS ONE, 2021, 16 (03):
  • [5] EMBARK: A Randomized, Controlled Trial Comparing Three Approaches to Reducing Diabetes Distress and Improving HbA1c in Adults With Type 1 Diabetes
    Hessler, Danielle M.
    Fisher, Lawrence
    Guzman, Susan
    Strycker, Lisa
    Polonsky, William H.
    Ahmann, Andrew
    Aleppo, Grazia
    Argento, Nicholas B.
    Henske, Joseph
    Kim, Sarah
    Stephens, Elizabeth
    Greenberg, Katherine
    Masharani, Umesh
    [J]. DIABETES CARE, 2024, 47 (08)
  • [6] THE EFFECT OF MOTIVATIONAL INTERVIEW AND INTENSIVE EDUCATION ON HBA1C VALUES AND GLUCOSE VARIABILITY IN POORLY CONTROLLED TEENS WITH TYPE 1 DIABETES
    Pulkkinen, M. A.
    Tuomaala, A. K.
    Kaunisto, K.
    Ojaniemi, M.
    Tossavainen, P.
    Sarkola, T.
    Miettinen, P.
    Laine, T.
    Lapatto, R.
    Wehkalampi, K.
    Hero, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A59 - A59
  • [7] Text-message responsiveness to blood glucose monitoring reminders is associated with HbA1c benefit in teenagers with Type 1 diabetes
    McGill, D. E.
    Volkening, L. K.
    Butler, D. A.
    Wasserman, R. M.
    Anderson, B. J.
    Laffel, L. M.
    [J]. DIABETIC MEDICINE, 2019, 36 (05) : 600 - 605
  • [8] HbA1c and microvascular complications in type 1 diabetes
    Pavlicek, Vojtech
    [J]. DIABETOLOGIE, 2023, 19 (01): : 79 - 80
  • [9] HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial
    Knowler, William C.
    Edelstein, Sharon L.
    Goldberg, Ronald B.
    Ackermann, Ronald T.
    Crandall, Jill P.
    Florez, Jose C.
    Fowler, Sarah E.
    Herman, William H.
    Horton, Edward S.
    Kahn, Steven E.
    Mather, Kieren J.
    Nathan, David M.
    [J]. DIABETES CARE, 2015, 38 (01) : 51 - 58
  • [10] Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial
    Jefferies, Craig A.
    Boucsein, Alisa
    Styles, Sara E.
    Chamberlain, Bronte
    Michaels, Venus R.
    Crockett, Hamish R.
    De Lange, Michel
    Lala, Anita
    Cunningham, Vicki
    Wiltshire, Esko J.
    Serlachius, Anna S.
    Wheeler, Benjamin J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 827 - 835